On October 28, 2023, the 5th International Innovative Drug Development Summit Forum at the School of Chinese Medicine of Hong Kong Baptist University will commence. Dr. Li Ming, CEO of ZSHK Laboratories Limited（hereinafter referred to as "ZSHK"）, has been invited to attend and will deliver a keynote speech on the topic of " Key Considerations in Early Druggability Evaluation of Chemical Drugs" during the second session (Strategy and Translational Practice of New Drug Discovery and Development in the New Era) in the afternoon. Participants from all walks of life are welcome to engage in discussionsand exchanges.

This summit forum will take place in person or via video conference, delving into the future development of innovative drug development and traditional Chinese medicine in Hong Kong, and exploring the following three main themes:

1. New Horizons in Deciphering the Ecological Construction and Investment for New Drug Discovery and Development
2. Strategy and Translational Practice of New Drug Discovery and Development in the New Era
3. Innovator Insights into New Drug Discovery and Development

The conference will provide English and Mandarin as the languages of communication, serving as a platform for sharing and learning about the latest insights in the field of innovative drug